Budesonide induction and maintenance therapy for Crohnʼs disease during pregnancy
Inflammatory Bowel Diseases2008Vol. 15(1), pp. 25–28
Citations Over TimeTop 10% of 2008 papers
Dawn B. Beaulieu, Ashwin N. Ananthakrishnan, Mazen Issa, Lydia Rosenbaum, Sue Skaros, Julianne Newcomer, Randall S. Kuhlmann, Mary F. Otterson, Jeanne Emmons, Josh F. Knox, David G. Binion
Abstract
Budesonide may be a safe option for treatment of CD during pregnancy.
Related Papers
- → Vedolizumab for induction and maintenance of remission in Crohn’s disease(2020)1 cited
- → Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease(2010)14 cited
- → Targeted delivery of oral budesonide (Entocort® capsules) in healthy volunteers and Crohn's disease patients(2001)1 cited
- → The Phase 3 Trials of Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease(2017)
- → Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn’s disease patients with secondary loss of response during ustekinumab maintenance therapy: week 16 results from the phase 3b POWER trial(2023)